Marc Beer has had repeated success during his nearly three-decade career. Beer took several companies to success because he has mastered the development of unique solutions that work to solve problems that are pressing and immediate. He got his bachelor in 1987 from Miami University.
Marc Beer began his career in the sales and marketing of the pharmaceutical industry. He was Global Marketing Vice President at Genzyme, traded as GENZ on the NASDAQ. Beer promoted the product line which is geared to over 350 million people who are underserved medically and took Genzyme to the world. There are over 7,000 rare diseases that affect people.
Result of Helping
Marc Beer decided to do more after helping those that are not properly served by the medical industry. Beer wanted to address the issues that were hard to solve in the pharmaceutical industry and used his experience to start his first company.
Marc Beer launched ViaCell during 2000 after gaining experience with the sales and marketing of pharmaceuticals. The company had 300 employees and went public during 2005 as the biotechnology company VIAC on the NASDAQ. The company’s specialty was collecting and preserving stem cells from umbilical cord blood for the development of treatments for conditions affecting the human body.
Sell of VIACELL
Marc Beer sold ViaCell for $300 million to PerkinElmer seven years after its founding. Beer was experiencing vast success, and he had a full family life. This is when things went wrong. Marc Beer’s wife was only 42 when she died from a pulmonary embolism shortly after he sold the company. Beer began raising his children full time, until two years after his wife’s death his daughter told him it was time to create a new company. Learn more: https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues
A Phone Call
Marc Beer is the CEO, Chairman, and co-founder of Renovia. A phone call from Dr. Ray Iglesias, a gynecologist is what gave Beer the idea. Iglesias spent almost 40 years doing surgery on the pelvic floor, and a decade of that was trying to figure out how to help women avoid having the surgery. This led to Renovia which is focused on giving diagnosis and treatment before the need for surgery.